Empirical Financial Services LLC d.b.a. Empirical Wealth Management expanded its investment in Eli Lilly and Company (NYSE:LLY) by 6.9% in the second quarter, accumulating an additional 887 shares. By quarter’s end, the fund owned a total of 13,747 shares, reflecting continued confidence in the pharmaceutical leader.
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Boosts Holdings in Eli Lilly and Company $LLY

Key Takeaways:
- Empirical boosted its stake in Eli Lilly by 6.9% in Q2
- An additional 887 shares were acquired, raising the total to 13,747
- HoldingsChannel provided the data for this investment shift
- The expansion suggests a positive outlook on Eli Lilly’s performance
- The Lincolnian Online first published these findings
Empirical’s Second-Quarter Drive
Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its investment in Eli Lilly and Company, one of the world’s foremost pharmaceutical firms, by 6.9% during the second quarter. This move underscores the firm’s commitment to the drugmaker amid a competitive and evolving healthcare market.
Additional Shares Acquired
According to HoldingsChannel, the fund added 887 Eli Lilly shares during the quarter. As a result, Empirical Wealth Management’s stake increased to a total of 13,747 shares. The boost highlights the fund’s ongoing confidence in Eli Lilly’s growth potential and market position.
Why the 6.9% Increase Matters
A 6.9% uptick in holdings can be more than just a small maneuver. It points to the fund’s strategic interest in a stock that has consistently attracted investors looking for strong returns in the pharmaceutical sector. This expansion might reflect positive sentiment based on Eli Lilly’s performance and pipeline developments.
Looking Ahead
Though the company’s future performance was not discussed in the original content, Empirical’s decision to heighten its stake speaks volumes about its current outlook. With 13,747 shares now under management, the firm’s actions signal a measured endorsement of Eli Lilly’s track record and prospects.
Source and Timing
This information, reported by HoldingsChannel and published by The Lincolnian Online on October 3, 2025, underscores the transparent nature of financial updates for publicly traded entities. Investors who track these shifts often watch for changes that might signal broader trends or confidence in a company’s fundamentals.